PR Newswire BiotechOriginal article
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Positive
AI Analysis
Summary
bioAffinity Technologies announced a $4 million registered direct financing of common stock and concurrent private placement priced at-the-market under Nasdaq rules, facilitated by WallachBeth Capital.
Importance:4/10
Sentiment:
0.30
capital marketsregistered direct offeringprivate placementat-the-market pricingnasdaq
Related Companies
Read the original article
Published by PR Newswire Biotech on October 8, 2026 5:30 PM